Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M576Revenue $M158Net Margin (%)-20.7Altman Z-Score0.7
Enterprise Value $M753EPS $-1.4Operating Margin %-10.8Piotroski F-Score5
P/E(ttm)--Beneish M-Score152Pre-tax Margin (%)-20.2Higher ROA y-yY
Price/Book3.810-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %-19.1Current Ratio3.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-12.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-28.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M28.6ROIC % (ttm)-29.9Gross Margin Increase y-yN

Gurus Latest Trades with AEGR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEGRMichael Price 2014-12-31 Sold Out -1%$19.66 - $35.02
($25.02)
$ 20.16-19%Sold Out0
AEGRGeorge Soros 2014-12-31 Sold Out -0.01%$19.66 - $35.02
($25.02)
$ 20.16-19%Sold Out0
AEGRJoel Greenblatt 2014-12-31 Sold Out $19.66 - $35.02
($25.02)
$ 20.16-19%Sold Out0
AEGRGeorge Soros 2014-09-30 Buy 0.01%$26.93 - $35.65
($30.96)
$ 20.16-35%New holding25,000
AEGRJoel Greenblatt 2014-09-30 Buy $26.93 - $35.65
($30.96)
$ 20.16-35%New holding10,964
AEGRMichael Price 2014-03-31 Buy 1.1%$43.65 - $73.75
($59.26)
$ 20.16-66%New holding200,000
AEGRGeorge Soros 2012-06-30 Sold Out -0.01%$11.76 - $16.96
($14.02)
$ 20.1644%Sold Out0
AEGRGeorge Soros 2011-06-30 Buy 0.01%$15.29 - $21.85
($17.62)
$ 20.1614%New holding37,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEGR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AEGR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fitzpatrick Mark J.CFO 2014-08-19Buy1,150$30.64-33.49 view
Beer Marc DCEO 2014-07-31Buy10,000$33.65-39.44 view
Beer Marc DCEO 2014-06-03Buy10,000$30.12-32.34 view
Beer Marc DCEO 2014-05-27Buy10,000$31.59-35.49 view
Beer Marc DCEO 2014-05-20Buy10,000$30.53-33.25 view
Beer Marc DCEO 2014-05-08Buy30,000$35.31-42.28 view
VANLENT ANNEDirector 2014-05-08Buy4,000$33.78-39.67 view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-04-30Sell2,250$43.55-53.2 view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-03-31Sell2,250$46.2-55.89 view
Sumeray MarkChief Medical Officer 2014-03-14Sell2,000$51.34-60.3 view

Press Releases about AEGR :

    Quarterly/Annual Reports about AEGR:

      News about AEGR:

      Articles On GuruFocus.com
      Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
      Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
      Weekly CEO Buys Highlight: GEO, TRUE, BANC, AEGR, CLMS Jun 02 2014 
      Three CEOs Reporting Large Insider Buys May 22 2014 
      Four CEOs Reporting Large Insider Buys May 09 2014 
      100 Stocks at All-Time Highs | 60 Dividend Stocks Below the Results Feb 19 2013 
      My 3 Favorite Dividend Stocks at All-Time-Highs | Stock List Dec 27 2012 
      Weekly CFO Buys Highlight: RXN, XBKS, STAG, AEGR, PZG Apr 02 2012 

      More From Other Websites
      Aegerion Pharmaceuticals Achieves Primary Endpoint in Phase III Study of Lomitapide in Japanese... May 26 2015
      7:10 am Aegerion Pharma announces it has achieved the primary endpoint in its Phase III Study of... May 26 2015
      Aegerion Pharmaceuticals Achieves Primary Endpoint in Phase III Study of Lomitapide in Japanese... May 26 2015
      AEGERION PHARMACEUTICALS, INC. Financials May 16 2015
      CFO Moves: Arista Networks, 3D Systems, Aegerion Pharmaceuticals May 15 2015
      AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other... May 14 2015
      Aegerion Pharmaceuticals Announces Resignation of Chief Financial Officer May 14 2015
      Aegerion Pharmaceuticals Announces Resignation of Chief Financial Officer May 14 2015
      Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program May 11 2015
      Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program May 11 2015
      10-Q for Aegerion Pharmaceuticals, Inc. May 10 2015
      AEGERION PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 08 2015
      Aegerion's Q1 Loss Narrower than Expected, View Retained - Analyst Blog May 05 2015
      Aegerion Pharmaceuticals Announces First Quarter 2015 Financial Results May 04 2015
      Aegerion Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today May 04 2015
      Aegerion reports 1Q loss May 04 2015
      Aegerion reports 1Q loss May 04 2015
      AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 04 2015
      Aegerion Pharmaceuticals Announces First Quarter 2015 Financial Results May 04 2015
      Sarissa Capital's biotech bets May 04 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK